Clinical Study to Evaluate the Safety and Efficacy of IM21 CAR-T Cells in the Treatment of Elderly Patients With Relapsed or Refractory Multiple Myeloma

Name: Clinical Study to Evaluate the Safety and Efficacy of IM21 CAR-T Cells in the Treatment of Elderly Patients With Relapsed or Refractory Multiple Myeloma
Published: 2020
License: Public Domain

Beijing Immunochina Medical Science & Technology Co., Ltd. · 2020

ClinicalTrials.gov · Datasets · License: Public Domain · 2020

Open Source ↗

multiple-myeloma

multiple myeloma, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Clinical Study to Evaluate the Safety and Efficacy of IM21 CAR-T Cells in the Treatment of Elderly Patients With Relapsed or Refractory Multiple Myeloma

Related documents